Morgan Stanley’s Neovasc Inc. NVCN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,001
Closed -$87.5K 7828
2023
Q1
$87.5K Sell
3,001
-634
-17% -$17.3K ﹤0.01% 6064
2022
Q4
$57.4K Sell
3,635
-945
-21% -$7.76K ﹤0.01% 6232
2022
Q3
$31K Buy
4,580
+3,155
+221% +$21.8K ﹤0.01% 6616
2022
Q2
$9K Sell
1,425
-3,620
-72% -$25.1K ﹤0.01% 7259
2022
Q1
$54K Buy
5,045
+2,486
+97% +$27.7K ﹤0.01% 6673
2021
Q4
$30K Sell
2,559
-3,060
-54% -$52.2K ﹤0.01% 7054
2021
Q3
$102K Sell
5,619
-68
-1% -$1.36K ﹤0.01% 6369
2021
Q2
$131K Buy
5,687
+8
+0.1% +$182 ﹤0.01% 6225
2021
Q1
$153K Buy
5,679
+360
+7% +$12.2K ﹤0.01% 5806
2020
Q4
$126K Buy
5,319
+544
+11% +$17.5K ﹤0.01% 5814
2020
Q3
$256K Buy
4,775
+3,326
+230% +$192K ﹤0.01% 4981
2020
Q2
$86K Sell
1,449
-1,072
-43% -$66.9K ﹤0.01% 5478
2020
Q1
$92K Buy
2,521
+1,470
+140% +$97.8K ﹤0.01% 5220
2019
Q4
$142K Buy
1,051
+42
+4% +$3.57K ﹤0.01% 5541
2019
Q3
$97K Buy
1,009
+873
+642% +$75.1K ﹤0.01% 5455
2019
Q2
$16K Sell
136
-273
-67% -$33.9K ﹤0.01% 6008
2019
Q1
$43K Buy
409
+221
+118% +$33.1K ﹤0.01% 5736
2018
Q4
$28K Sell
188
-87
-32% -$33.6K ﹤0.01% 5944
2018
Q3
$187K Buy
275
+26
+10% +$22.4K ﹤0.01% 5485
2018
Q2
$266K Buy
+249
New +$258K ﹤0.01% 5429
2018
Q1
Hold
0
6747
2017
Q4
Hold
0
6317
2017
Q3
Hold
0
6074
2017
Q2
Sell
-1
Closed -$38.4K 6186
2017
Q1
$28K Buy
+1
New +$37.9K ﹤0.01% 5987
2016
Q2
Hold
0
6709
2016
Q1
Hold
0
6778
2015
Q4
Sell
-2
Closed -$230K 6425
2015
Q3
$293K Buy
2
+1
+100% +$143K ﹤0.01% 4895
2015
Q2
$127K Buy
+1
New +$193K ﹤0.01% 5465

Morgan Stanley's NVCN Position: Q2 2023 in Review

Morgan Stanley sold out of Neovasc Inc. (NVCN) in Q2 2023, closing a stake of 3,001 shares — an estimated $87.5K sold.

Morgan Stanley first reported a position in NVCN in Q2 2015 and held it in 23 quarters. The position peaked at $293K in Q3 2015. 0 funds tracked by Wall St. Rank hold NVCN as of Q2 2023.

  • Morgan Stanley reported no remaining Neovasc Inc. position as of Q2 2023 after selling out during the quarter.
  • Morgan Stanley sold 3,001 Neovasc Inc. shares in Q2 2023, an estimated $87.5K.
  • Morgan Stanley first reported a position in Neovasc Inc. in Q2 2015 and held it in 23 quarters.
  • Morgan Stanley's Neovasc Inc. position peaked at $293K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held Neovasc Inc. as of Q2 2023.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.